+116.8%
COST vs THC
+247.4%
-130.7%
-31.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -3.8% | +2.6% | -0.7% |
| 7D | +0.8% | -7.4% | +8.2% | +1.9% |
| 30D | +10.3% | +1.9% | +8.5% | +9.9% |
| 3M | +14.2% | +0.4% | +13.8% | +14.0% |
| 6M | +2.2% | +41.0% | -38.8% | -3.3% |
| YTD | +27.9% | +36.5% | -8.6% | +21.1% |
| 1Y | +23.2% | +40.6% | -17.4% | +15.9% |
| 3Y | +97.6% | +325.7% | -228.1% | +49.9% |
| All | +116.8% | +247.4% | -130.7% | +68.9% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling